百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

交易中 11-11 11:58:24

250.800

-1.400

-0.56%

最高254.800	最低248.800	成交量128.13万
今开253.400	昨收252.200	日振幅2.38%
总市值3,867亿	流通市值3,579亿	总股本15.42亿
成交额3.22亿	换手率0.09%	流通股本14.27亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":250.8,"timestamp":1794369487962,"preClose":252.2,"halted":0,"volume":1281348,"delay":0,"changeRate":-0.005551149881046698,"floatShares":1427000000,"shares":1542000000,"eps":1.490640347711475,"marketStatus":"交易中","change":-1.4,"latestTime":"11-11 11:58:24","open":253.4,"high":254.8,"low":248.8,"amount":321577428,"amplitude":0.023791,"askPrice":251,"askSize":4100,"bidPrice":250.8,"bidSize":10600,"shortable":3,"etf":0,"ttmEps":4.714024572029311,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1794369600000},"marketStatusCode":2,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":252.2,"openAndCloseTimeList":[[1794360600000,1794369600000],[1794373200000,1794384000000]],"volumeRatio":0.45718,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":283.45,"timestamp":1794367795000,"preClose":285.45,"halted":0,"volume":1966800,"delay":0,"premium":"-24.73"},"impliedVol":0.4454,"impliedVolPercentile":0.8408},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2682341703","title":"百济神州（688235）2026年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2682341703","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682341703?lang=zh_cn&edition=full","pubTime":"2026-11-11 06:02","pubTimestamp":1794348132,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百济神州发布2026年三季报。截至本报告期末，公司营业总收入349.93亿元，同比上升26.81%，归母净利润60.55亿元，同比上升431.81%。按单季度数据看，第三季度营业总收入127.74亿元，同比上升26.76%，第三季度归母净利润27.85亿元，同比上升304.25%。本报告期百济神州盈利能力上升，毛利率同比增幅3.55%，净利率同比增幅319.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100009297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682906603","title":"百济神州再次上调业绩预期，百悦泽撑起超七成营收","url":"https://stock-news.laohu8.com/highlight/detail?id=2682906603","media":"东方财富网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682906603?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:21","pubTimestamp":1794313316,"startTime":"0","endTime":"0","summary":"11月9日，百济神州（688235.SH）发布2026年三季度报告。公告显示，第三季度公司实现营收127.74亿元，同比增长26.8%；归母净利润27.85亿元，同比增长304.3%。此外，百济神州已在年内三次上调年度经营业绩预期。第三次调整后，营收指引上调至463—470亿元，经营利润指引则从65—71亿元大幅拉升至84—90亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202611103927505112.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202611103927505112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["ONC","688235","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682393697","title":"百济神州9月30日股东户数3.76万户，较上期减少4.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682393697","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682393697?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:50","pubTimestamp":1794304200,"startTime":"0","endTime":"0","summary":"证券之星消息，近日百济神州披露，截至2026年9月30日公司股东户数为3.76万户，较6月30日减少1969.0户，减幅为4.98%。户均持股数量由上期的2911.0股增加至3064.0股，户均持股市值为81.01万元 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261110/c681668230.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261110/c681668230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LU1719994722.HKD","LU1251922891.USD","LU2328871848.SGD","BK1161","06160","BK1583","LU0588546209.SGD","BK4139","BK4526","LU1303224171.USD","BK0239","688235","BK1588","LU0307460666.USD","LU1770034418.SGD","LU0228659784.USD","KURE","BK4588","BK4585","LU0828237510.HKD","BK1500","ONC","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682393323","title":"海量财经 | 百济神州三季报：单季归母净利增逾三倍，年内第三次上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2682393323","media":"海报新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682393323?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:26","pubTimestamp":1794302760,"startTime":"0","endTime":"0","summary":"海报新闻记者张逸飞报道11月9日，百济神州（688235.SH；06160.HK；ONC.US）披露2026年第三季度报告。第三季度，公司实现营业收入127.74亿元，同比增长26.8%；归属于上市公司股东的净利润27.85亿元，同比增长304.3%；扣非归母净利润26.50亿元，同比增长274.1%。按此计算，第三季度净利润较第二季度的16.63亿元环比增长约67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611103927397820.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611103927397820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1303224171.USD","BK1583","BK1161","BK4588","688235","LU0228659784.USD","LU1770034418.SGD","ONC","LU0828237510.HKD","BK4139","BK4526","BK4585","LU1969619763.USD","LU1719994722.HKD","06160","LU0588546209.SGD","LU0307460666.USD","BK0239","BK1500","LU1251922891.USD","KURE","BK1588","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164973708","title":"百济神州：The Capital Group Companies, Inc.增持，好仓比例升至9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164973708","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164973708?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:12","pubTimestamp":1794301927,"startTime":"0","endTime":"0","summary":"The Capital Group Companies, Inc.于2026年11月6日在联交所场内以每股均价245.2459港元买入百济神州（06160）股份211.50万股，涉资约5.19亿港元，属场内主动交易，即在二级市场直接买卖股份。The Capital Group Companies, Inc.此次增持前持有百济神州好仓1.38亿，占比8.95%；增持后持股量为1.40亿，好仓比例升至9.09%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682180363","title":"大行评级｜大和：百济神州第三季业绩超预期并上调全年指引，目标价升至476美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682180363","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682180363?lang=zh_cn&edition=full","pubTime":"2026-11-10 14:16","pubTimestamp":1794291415,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["06160","BK4139","LU0228659784.USD","LU0307460666.USD","BK4526","BK0239","LU1719994722.HKD","BK1161","688235","BK4585","BK4588","LU1303224171.USD","BK1583","LU0588546209.SGD","BK1500","LU0828237510.HKD","BK1588","LU1770034418.SGD","ONC","LU2328871848.SGD","LU1251922891.USD","UUP","LU1969619763.USD","UDN","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682363773","title":"研发投入强度是否会保持？哪款产品将支撑业绩成为“重磅炸弹”？百济神州业绩说明会释疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2682363773","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682363773?lang=zh_cn&edition=full","pubTime":"2026-11-10 14:14","pubTimestamp":1794291293,"startTime":"0","endTime":"0","summary":"11月10日上午，百济神州（688235）举行2026年第三季度业绩说明会。公司多名高管参加活动，与投资者展开交流。资料显示，百济神州有限公司的主营业务是研究、开发、生产以及商业化创新型药物。公司的主要产品是抗肿瘤类药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611103927252982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611103927252982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0588546209.SGD","LU0828237510.HKD","BK1583","LU1251922891.USD","ONC","BK4585","BK1161","LU1770034418.SGD","LU0228659784.USD","LU1969619763.USD","BK0239","06160","LU2328871848.SGD","KURE","LU0307460666.USD","BK1588","BK1500","BK4139","BK4526","688235","BK4588","LU1303224171.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682368032","title":"大和：上调百济神州(06160)目标价至286港元 第三季业绩再胜预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2682368032","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682368032?lang=zh_cn&edition=full","pubTime":"2026-11-10 13:56","pubTimestamp":1794290166,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，大和发布研报称，百济神州(06160)第三季业绩再胜预期，该行重申“买入”评级，目标价由270港元上调至286港元，并将2026至2028年每股盈利预测上调1%至15%。期内收入同比增长34%至18.9亿美元，当中产品收入同比增长33%至18.6亿美元，高于该行及市场预测，主要受Brukinsa销售胜预期带动。第三季经调整非公认会计准则净利润同比增长77%至5.39亿美元，亦胜该行及市场预期。公司继次季再次上调2026财年指引，预期收入69亿至70亿美元，非公认会计准则经营利润19亿至20亿美元。该行认为有关目标容易达成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","ONC","EWH","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682335477","title":"大行评级｜里昂：上调百济神州H股目标价至336.8港元，维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2682335477","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682335477?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:36","pubTimestamp":1794281799,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0828237510.HKD","BK1500","BK0239","BK1161","LU1969619763.USD","LU2328871848.SGD","LU0588546209.SGD","LU0228659784.USD","LU1303224171.USD","BK4139","LU1251922891.USD","LU0307460666.USD","LU1719994722.HKD","ONC","06160","BK1588","BK4588","BK4585","BK4526","KURE","688235","EWH","LU1770034418.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682552143","title":"港股异动 | 百济神州(06160)高开逾7% 前三季度经调整净利同比增长96% 花旗指百悦泽表现持续优于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2682552143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682552143?lang=zh_cn&edition=full","pubTime":"2026-11-10 09:28","pubTimestamp":1794274080,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百济神州高开逾7%，截至发稿，涨7.57%，报267港元，成交额8031.36万港元。消息面上，近日，百济神州公布2026年第三季度业绩，总收入约18.9亿美元，同比增长34%；产品收入净额约18.55亿美元，同比增长33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LU0203347892.USD","LU0828237510.HKD","BK4526","FTXO","LU0310800965.SGD","LU0072461881.USD","BK4566","LU0130102774.USD","BK1583","LU1303224171.USD","LU1969619763.USD","LU0648001328.SGD","LU0980610538.SGD","LU2264538146.SGD","LU1366192091.USD","ONC","TFNS","06160","LU1201861249.SGD","LU1668664300.SGD","LU2360032135.SGD","LU2328871848.SGD","LU2456880835.USD","LU0170899867.USD","BK1588","LU0314106906.USD","BK4559","BK1500","LU0128525689.USD","LU1791807156.HKD","688235","LU0052756011.USD","BK1161","KURE","LU1770034418.SGD","BK4207","BK4139","LU2125154935.USD","LU2125154778.USD","KCAI","LU0203345920.USD","IYF","LU0320765646.SGD","LU1144417596.USD","VXUS","LU1064131342.USD","LU0228659784.USD","LU1244550577.SGD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682382681","title":"百济神州三度上调2026年营收预测 基石性产品高增长之下，如何化解单品依赖风险？","url":"https://stock-news.laohu8.com/highlight/detail?id=2682382681","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682382681?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:21","pubTimestamp":1794237690,"startTime":"0","endTime":"0","summary":"近日，百济神州（SH688235）披露多份公告，在发布未经审计的2026年前三季度和第三季度初步财务数据之外，第三次上调全年经营业绩预测，同时公布前三季度资产减值计提情况。一边是商业化产品拉动收入增长，一边是出于会计审慎性考虑，计提资产减值，“一增一减”同步释放，勾勒出这家生物药企当前的经营格局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611093926596361.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611093926596361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","06160","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682389327","title":"百济神州（688235）披露2026年第三季度报告，11月9日股价上涨2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682389327","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682389327?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:03","pubTimestamp":1794233032,"startTime":"0","endTime":"0","summary":"近日，百济神州有限公司披露《2026年第三季度报告》。利润总额本报告期为2,962,357千元，同比增长296.9%；年初至报告期末为7,044,879千元，同比增长356.5%。归属于上市公司股东的净利润本报告期为2,784,523千元，同比增长304.3%；年初至报告期末为6,055,116千元，同比增长431.8%。研发投入合计本报告期为4,388,356千元，同比增长13.1%；年初至报告期末为12,340,973千元，同比增长10.6%。总资产本报告期末为66,654,210千元，同比增长16.3%；归属于上市公司股东的所有者权益为39,486,681千元，同比增长28.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900023692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","06160","BK1588","LU0228659784.USD","LU0307460666.USD","LU1303224171.USD","BK1583","LU1770034418.SGD","KURE","LU2328871848.SGD","LU1251922891.USD","LU0828237510.HKD","LU1719994722.HKD","LU0588546209.SGD","BK1500","LU1969619763.USD","BK1161","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192842084","title":"百济神州（06160）公布2026年三季报：前三季度营收349.93亿元 净利60.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192842084","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192842084?lang=zh_cn&edition=full","pubTime":"2026-11-09 19:01","pubTimestamp":1794222105,"startTime":"0","endTime":"0","summary":"2026年11月9日，百济神州披露2026年第三季度报告。公司在报告中列示的主要财务数据如下：。2026年前三季度累计实现营业收入349.93亿元，同比增长26.8%；归属于上市公司股东的净利润60.55亿元，同比增长431.8%。前三季度研发投入123.41亿元，占营业收入的35.3%，较上年同期下降5.1个百分点。截至9月30日，公司总资产666.54亿元，较上年度末增长16.3%；归属于上市公司股东的所有者权益394.87亿元，增长28.9%。本次季报未经审计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682808013","title":"前三季度净利润增长超四倍：百济神州三次上调业绩预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2682808013","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682808013?lang=zh_cn&edition=full","pubTime":"2026-11-09 16:33","pubTimestamp":1794213180,"startTime":"0","endTime":"0","summary":"11月6日，百济神州（688235）年内第三次上调业绩预期，2026年全年营业收入预测由449亿元至462亿元区间，升至463亿元至470亿元区间。2026年前三季度，百济神州营业总收入349.93亿元，同比增长26.8%；归母净利润60.55亿元，同比增长431.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611093926286680.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611093926286680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682687891","title":"大行评级｜大华继显：上调百济神州目标价至300港元，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2682687891","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682687891?lang=zh_cn&edition=full","pubTime":"2026-11-09 10:55","pubTimestamp":1794192915,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2328871848.SGD","LU1719994722.HKD","KURE","BK4585","BK4588","LU1770034418.SGD","LU0307460666.USD","BK1583","BK0239","LU0228659784.USD","LU0588546209.SGD","LU1251922891.USD","BK4139","688235","LU0828237510.HKD","ONC","EWH","BK1500","BK1588","BK4526","06160","BK1161","LU1303224171.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155670823","title":"异动解读｜百济神州盘中上涨3.28%，第三次上调全年营收与利润指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1155670823","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155670823?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:43","pubTimestamp":1794188583,"startTime":"0","endTime":"0","summary":"11月9日，百济神州盘中上涨3.28%，报252.2港元，成交额1.86亿港元。消息面上，公司披露三季度业绩后，年内第三次上调全年经营指引，强化了市场对其全球商业化放量与盈利持续提升的预期。数据显示，公司第三季度全球总收入19亿美元，同比增长34%；其中百悦泽全球收入14亿美元，同比增长34%。全年总收入指引上调至69亿至70亿美元；对应人民币口径，预计全年营业收入463亿至470亿元，营业收入扣除经营成本费用84亿至90亿元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州三度上调业绩指引，盘中走强","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682827557","title":"中国创新药长出全球竞争力！百济神州第三次上调业绩指引：预计全年营收463-470亿，利润84-90亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2682827557","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682827557?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:32","pubTimestamp":1794187920,"startTime":"0","endTime":"0","summary":"2025年，百济神州(688235.SH)第一次扭亏，2026年三季度又交出一份利润增速远超收入成绩单：营业总收入127.74亿元，同比增长26.8%；其中产品收入125.60亿元，同比增长26.2%。归母净利润27.85 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261109/c681592333.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261109/c681592333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688235","KURE","06160","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682214148","title":"港股概念追踪 | 欧洲资本组团来华扫货 中国创新药迈向海外商业化4.0时代(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682214148","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682214148?lang=zh_cn&edition=full","pubTime":"2026-11-09 07:18","pubTimestamp":1794179936,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，在上海举办的“FHIM2026全球医药合作与投资年会”上，10余家欧洲生命科学投资机构的负责人组团而来，目的是挖掘中国创新药产业链中的好资产。欧洲对中国药企具备突出的战略价值。另外，从产业互补的角度看，欧洲拥有的科研积淀、产业经验与资本生态，是中国创新药实现全球化升级的重要支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0828237510.HKD","LU0359201885.HKD","BK4585","LU0307460666.USD","LU0359201612.USD","09969","LU0228659784.USD","BK1161","BK4588","BK1588","LU0359202008.SGD","LU2543165471.USD","BK1583","01276","LU1969619763.USD","01877","LU2328871848.SGD","LU1251922891.USD","BK1191","BK1574","LU1023057109.AUD","BK1500","KCAI","LU1770034418.SGD","06160","VXUS","LU1719994722.HKD","LU0588546209.SGD","LU1303224171.USD","BK1515","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682082516","title":"股市必读：百济神州新发布《港股公告：百济神州有限公司截至2026年9月30日止三个月及九个月未经审核业绩以及业务进展最新情况》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682082516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682082516?lang=zh_cn&edition=full","pubTime":"2026-11-09 02:02","pubTimestamp":1794160943,"startTime":"0","endTime":"0","summary":"公司公告汇总港股公告：百济神州有限公司截至2026年9月30日止三个月及九个月未经审核业绩以及业务进展最新情况截至2026年9月30日止第三季度全球总收入19亿美元，同比增长34%；百悦泽全球收入14亿美元，同比增长34%；GAAP稀释每股ADS收益3.28美元，非GAAP为4.59美元；2026年全年总收入指引上调至69亿至70亿美元，GAAP经营利润指引为12亿至13亿美元，非GAAP经营利润为19亿至20亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900000584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","BK1583","LU1251922891.USD","LU0588546209.SGD","LU1303224171.USD","LU0307460666.USD","LU1770034418.SGD","BK1500","BK0239","06160","LU0228659784.USD","LU0828237510.HKD","LU1719994722.HKD","KURE","LU1969619763.USD","LU2328871848.SGD","BK1588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681484081","title":"百济神州三度上调2026年营收预测，基石性产品百悦泽高增长之下，如何化解单品依赖风险？","url":"https://stock-news.laohu8.com/highlight/detail?id=2681484081","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681484081?lang=zh_cn&edition=full","pubTime":"2026-11-08 18:31","pubTimestamp":1794133860,"startTime":"0","endTime":"0","summary":"近日，百济神州披露多份公告，在发布未经审计的2026年前三季度和第三季度初步财务数据之外，第三次上调全年经营业绩预测，同时公布前三季度资产减值计提情况。一边是商业化产品拉动收入增长 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261108/c681582321.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261108/c681582321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688235","ONC","06160"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":0.1998},{"period":"1month","weight":0.2032},{"period":"3month","weight":0.1644},{"period":"6month","weight":0.3655},{"period":"1year","weight":0.2907},{"period":"ytd","weight":0.4066}],"compareEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":0.0143},{"period":"3month","weight":-0.0347},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0785},{"period":"ytd","weight":-0.0419}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.043816},{"month":6,"riseRate":0.375,"avgChangeRate":0.001624},{"month":7,"riseRate":0.875,"avgChangeRate":0.102282},{"month":8,"riseRate":0.875,"avgChangeRate":0.065066},{"month":9,"riseRate":0.555556,"avgChangeRate":0.027524},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.026006},{"month":11,"riseRate":0.666667,"avgChangeRate":0.120508},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEONE MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}